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Abstract 
Introduction: Pharmaceutical expenditures have increased dramatically in most developed and developing countries in recent decades. 
Healthcare system policymakers have expressed concerns about the inappropriate, irrational, or harmful prescribing of drugs.  
Objectives: The attitudes of physicians towards prescribing generic drugs and predictors of perceived utility of drugs were investigated 
in the present study. Methods: In this cross-sectional research, 77 physicians at different levels of job hierarchies, working in various 
public sector shifts, were recruited to participate in a survey of their attitudes toward prescribing generic drugs in Iraqi Kurdistan in 
2018. The doctors were located in a general, an emergency, and a pediatric hospital. A self-administered structured questionnaire was 
designed based on the extended technology acceptance model for product use (TETPU). Results: The doctors agreed that drugs should 
be prescribed according to their utility for patients (median [M] = 5.0; interquartile range [IQR] = 2.9). Most of the physicians mentioned 
that they prescribed drugs according to the patients’ needs (75.0%), evaluation of the availability of alternatives (69.0%) and consumer 
perceptions of a price (69.0%). The analysis showed that (1) the importance of physicians’ perceptions and their recognition of patients’ 
need achievement (P=.012), (2) the physicians' recognition of the actual use of drugs by consumers (P=.030) and (3) being male (p=.009) 
were associated with perceptions of drug utility. Conclusions: The study’s results suggest that perceived drug utility in prescription 
writing is associated with physicians’ perceptions of need achievement and attitudes toward how patients actually use medicines.  
Keywords: Prescription; drug administration; doctors’ attitudes; perceived utility  
 
Introduction 
Pharmaceutical expenditures have increased dramatically in 
most developed and developing countries in recent decades 
and has raised concerns among healthcare policymakers about 
health systems’ sustainability.1 The Organization for Economic 
Cooperation and Development (OECD) has ranked 
pharmaceutical costs third among the largest medical 
expenditures, after inpatient and outpatient care, with 
prescribed drugs accounting for 17% of health expenditures 
across OECD countries in 2013. Hospitals’ pharmaceutical costs 
were not considered in this statistic.2 Healthcare system 
policymakers have thus expressed deep concern about 
inappropriate, irrational, or harmful drug prescribing.3  
Observational and experimental studies have found evidence 
that many patients are not always prescribed the best 
pharmaceutical therapies for their medical conditions. 4, 5 In 
addition, the overuse and misuse of pharmaceutical products 
has been substantiated. 4, 5 This trend could result in patients’ 
loss of health and quality of life and lead to increased 
healthcare expenditures and adverse events.6  
Using generic drugs is increasing in most countries worldwide 
to reduce health-associated costs.7 In mature healthcare 
systems, physicians urge their patients to use generic drugs  
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irrespective of their socioeconomic status or healthcare 
systems’ policies.8 In developed countries, physicians have 
positive perceptions, whereas those from low and middle-
income countries (LMIC) have mixed views about generic 
medicines.9 In Iraq, some physicians are against prescribing 
generic medicines, while others are more open-minded.10 
Therefore, the recommended optimal and established 
guidelines for prescribing generic drugs must be examined and 
monitored throughout the health sector. More specifically, the 
prohibition of dispensing medicines without prescriptions is 
poorly enforced in Iraqi Kurdistan.11 In addition, some generic 
drugs do not need a standardized written form. In Iraqi 
Kurdistan, the doctors are affected by receiving promotional 
materials and activities to prescribe a new drug, including 
medical samples (67.8%); funding of registration costs to 
conferences (60.1%); participation in industry-funded 
researches (69.9%); and continuing medical education 
(69.4%).12 
Various studies have sought to examine and interpret the 
factors that influence the behaviors and practices of physicians 
regarding prescribing drugs. In the past, many factors have 
been reported in the literature as having a role in tendencies of 
doctors to prescribe drugs. 13-15 Some factors cannot be 
changed, and they do not offer opportunities to make 
modifications or improvements, including gender, age, 
socioeconomic characteristics, and drug therapies’ 
reimbursement status.16, 17 Other factors have changed over 
time, and they can produce modifications in behaviors of 
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physicians to prescribe a drug. The latter factors include, among 
others, doctors’ medical experience, education level, and social 
factors.18  
Further factors affecting doctors to prescribe a particular drug 
are “opinion leaders” and medical specialists’ behaviors in 
medical networks.19 Opinion leaders’ significant role in deciding 
patterns of prescribing drugs has been reported by various 
investigators.20, 21 In addition, free drug samples given to 
physicians with varied levels of experience have been shown to 
have an impact on prescription generation.22 Tan and 
colleagues23 reported that medical training, patient factors, 
drug costs, and disease definition in primary health systems 
play a role in family physicians’ patterns of prescribing asthma 
drugs.  
A study conducted in Greece and Cyprus showed that clinical 
effectiveness is a factor given significant weight in prescribing 
drugs. Generic drugs’ safety and efficacy were not considered 
crucial factors by physicians in these two countries.24 Generic 
drug products are defined as interchangeable with brand 
pharmaceuticals. The former is manufactured with a license 
obtained after the expiration of drugs’ patent and exclusive 
rights.25  
Policymakers rely on existing investigations to determine the 
measures needed to enhance health policies’ effectiveness and 
ensure greater economic and clinical efficiency. Notably, no 
prior study has specifically focused on predictors of doctors’ 
perceptions of drug utility, which is one of the most important 
factors in prescribing drugs. The definition of perceived utility 
was adapted from Sanyal et al.26 They mentioned that 
“perceived utility of generic drugs refers to the physicians’ 
overall assessment of the utility based on the perceptions of 
what is actually obtained from generic drugs, easy availability, 
the effectiveness of physician job and the satisfaction of 
physicians’ needs for better quality.”  
To fill this research gap, the current study explored the 
attitudes of physicians towards prescribing generic drugs. In 
addition, predictors of the perceived utility of generic drugs 
were examined in the context of prescribing generic drugs for 
an Iraqi Kurdistan physician’s sample. 
 
Methods 
Study design and subjects  
In this cross-sectional study, 142 physicians with different levels 
of education and medical experience were contacted through 
the relevant clinical department secretary. The doctors had 
different specialties and worked in three public hospitals: a 
general, an emergency, and a pediatric facility. These hospitals 
with various specialties were included in the study to cover 
different physicians’ attitudes. Only doctors who could 
prescribe drugs were invited, so the respondents did not belong 
to specialties such as radiology, microbiology, hematology, 
forensic medicine, and anesthesiology. In line with the research 
objectives, the doctors were selected from different shifts and 
clinical settings. Since the respondents’ work shifts were 
changeable, the sample could not be selected randomly.  
Of the total 142 invited physicians, 86 of them returned the 
questionnaire yielding a response rate of 60.6%.  Nine 
physicians did not complete the whole questionnaire, so they 
were excluded from the data analyzed. In addition, 56 doctors 
did not participate due to their workloads and therapeutic 
procedures.  
We expected that the physicians might have not sufficient 
information and experience about new generic drugs (the 
generic drugs were entered into the pharmaceutical market for 
the last three years). Therefore, the respondents were not 
requested to report on their attitudes toward prescribing new 
drugs.  
The time required to fill out the entire questionnaire was 10 
minutes. The study was conducted in three hospitals in 
Erbil/Iraqi Kurdistan between October and November 2018. 
The participation of the subjects was optionally and 
anonymously.  
 
Data collection and measurement 
The doctors’ general information was gathered with a self-
administered questionnaire, including age, gender, and 
placement in job hierarchies. The latter included the categories 
of junior house officer, senior house officer, general 
practitioner, specialist, and consultant. In addition, items asked 
the respondents to be specific if they work in the public, private, 
or both sectors and work mornings (8 a.m.–2 p.m.), evenings (2 
p.m.–8 p.m.), nights (8 p.m.–8 a.m.), or multi-shift schedules 
(i.e., in line with the local health system). The demographic data 
were used as confounders to obtain more robust assessments 
of the doctors’ perceptions of generic or branded generic drugs.  
 
A structured questionnaire based on the extended technology 
acceptance model for product usage (TETPU) was used to 
measure the physicians’ attitudes toward prescribing generic 
drugs. The measurement instrument has been developed 
according to the strategic, comprehensive model.27 The TETPU 
model is based on the strategic, comprehensive branding 
model.27 The constructs were used to establish this model were 
product brand equity, corporate brand equity, perceived cost, 
perceived utility, opinion leaders, availability of alternatives, 
brand age, perceived no need, physicians; physicians’ 
perception and need achievement, physicians’ attitude, 
prescription intention, demographic variables, and actual use.   
The constructs included in the present model were defined as 
follow:  
Perceived utility: “Perceived utility of generic drugs referred to 
the physicians’ overall assessment of the drug utility based on 
the perceptions of what is actually obtained from generic drugs, 
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easy availability, the effectiveness of physician job and the 
satisfaction of physicians’ needs for better quality”.28 The 
perceived utility was assessed with five items, namely, 
perceptions of prescribing drug according to drug efficacy, and 
generic drug tolerability, easy availability, patient satisfaction, 
and physicians’ on-the-job effectiveness. Physicians’ on-the-job 
effectiveness was defined as a clinical improvement as the 
result of prescribing a generic drug.  
The perceived ease of use was considered to be redundant in 
explaining the prescribing attitude of the physicians in this 
model.26 Therefore, in line with the model, it was not included 
in the measurement.  
Perceived no need: It was defined as a physician prescribes a 
drug to a patient when the patient needs it.  
Availability of alternatives: It was defined as a physician 
prescribes a drug to the patient when evaluating the availability 
of drug alternatives. 
Perceived cost: it was defined as a physician prescribes a drug 
to a patient when it considers the consumer’s perceptions of a 
price.  
Importance of product brand equity: it was defined as a 
physician who prefers a brand of drug to another one to 
prescribe it.  
Importance of corporate brand equity: It was defined as the 
sustainability of a brand of a drug for the doctor to prescribe it. 
The features of the drug were not included in this item. The 
significant advantages of the drug were considered in corporate 
brands. The advantages were trust, loyalty, and scientific 
credibility for its research and development, credibility to its 
sales force and creation of a new product launching 
environment.” 
Importance of opinion leaders as communicators of the brand: 
it was defined as considering the opinion leaders in prescribing 
a generic drug. The leaders refer to health policymakers, 
hospital managers, or clinical supervisors.  
Importance of physicians’ perceptions and need achievement: 
It was referred to as the perception and recognition of the 
physicians of the patients’ needs. In other words, the physician 
prescribes a drug based on the recognition of the patient’s 
needs.  
Importance of pharma brand age in brand awareness: It was 
referred to the importance of pharma brand age among 
customers.  
Attitude toward branded generics: It was defined as a 
physician prescribes a drug to the patient according to the 
patients’ attitudes towards drugs’ favorability.  
Prescription intention: it was defined as the physician 
recognized that a patient intended to purchase a drug.  
Consumers’ intentions/attitudes: It was defined as the 
physician considers the importance of the drugs to the patients.   
 Actual use of consumers: it was defined as the physician 
considers the actual use of the drugs by the patients to 
prescribe a drug.26 
The study questionnaire included the following sections: 
Perceive utility: The physicians were asked to respond to the 
following question items when they prescribe the drugs to 
patients.  
 I prescribe the drugs to patients according to their efficacy.   
 I prescribe the drugs to patients according to the 
tolerability of the branded generics. 
 I prescribe the drugs to patients according to easy 
availability. 
 I prescribe the drugs to patients according to the patient’s 
satisfaction. 
 I prescribe the drugs to patients according to the 
effectiveness of the physician job. 
Other factors: Some other question items were used to 
examine the doctors’ attitudes towards prescribing drugs to the 
patients. The factors were: 
 I prescribe the drugs according to the patients’ needs. 
 I prescribe the drugs to patients according to the 
evaluation of alternatives availability.  
 I prescribe the drugs according to consumer perceptions of 
price. 
 I prescribe the drugs according to product brand equity. 
 I prescribe the drugs according to corporate brand equity. 
 I prescribe the drugs according to opinion leaders’ 
influence. 
 I prescribe the drugs according to the importance of 
physicians’ perceptions and need achievement. 
 I prescribe the drugs according to the importance of the 
pharma brand age in brand awareness. 
 I prescribe the drugs according to the importance of 
customers’ attitudes towards drug’s favorability.  
 I prescribe the drugs according to consumers’ intend to 
purchase. 
 I prescribe the drugs according to the consumer’s 
intentions/attitudes. 
 I prescribe drugs according to the actual use of consumers. 
The responses were given on a 7-point Likert scale (1 = 
“Strongly disagree”; 7 = “Strongly agree”). The scale’s internal 
consistency reliability was confirmed with a Cronbach’s alpha 
value of 0.767 for perceived utility and more than 0.700 for 
other items. The questionnaire was administered in the original 
language (i.e., English) to the respondents because schools’ 
official language in the region under study is English.  
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Statistical analysis  
The normality of the participants’ information including age and 
their attitudes towards drug prescription was tested in the 
Shapiro-Wilk test. The significant P-value of the result was 
considered to be non-normally distributed information. The 
doctors’ attitudes toward prescribing generic drugs were 
quantified in terms of the median and interquartile range (IQR), 
while categorical variables were estimated by frequency and 
percentage.  
The mean and standard deviation of five question items were 
measured to obtain the overall score of perceived utility. The 
perceived utility of prescribing generic drugs was transformed 
into a two-step to create a normally distributed dependent 
variable. Accordingly, the predictors of perceived drug utility 
among physicians were examined using either linear 
regression. The Box's M test was performed for the 
independent variables (P=0.286). Multivariate analysis was 
performed to examine the predictors of perceived utility 
question items. The null hypothesis was determined based on 
a p-value of less than 0.05. The statistical calculations were 
performed using the IBM Statistical Package for Social Sciences 
version 25 software. A random sample could not be obtained 
from the target population as the doctors in question were not 
all present in one setting or shift, and some were not available 
during the data collection period due to their workloads and/or 
therapeutic, diagnostic, or surgical procedures.  
 
The sample size was estimated using Slovin’s formula as shown 
in Equation (1): n = N/(1 + Ne2) 
in which n is the sample size, N is the target population, and e 
is an error tolerance of 5%. The total number of doctors in the 
3 hospitals who were eligible for the study was 220. The total 
sample invited to participate in this research was 142 doctors. 
Of these, 86 agreed to participate, resulting in a response rate 
of 60.6%. The net percent of respondents included after 
excluding the missing questionnaires, which represented more 
than 20% of the data, was 77/142 or 54.22%.  
 
Ethical review 
The present study’s ethical approval was obtained from the 
Scientific Research Division’s Directorate of Planning, and the 
General Directorate of Health—Erbil, and the study was 
registered under the number 638 on January 14th, 2018. The 
research’s aims were explained to the doctors, and their verbal 
consent was given prior to data collection.  
 
Results 
The physicians’ median age was 33.0 (interquartile range [IQR] 
= 12.5; range = 25–70 years). Of the 77 doctors who 
participated in the present study, more than half were males 
(58.4%). Most were senior house officers (39.0%), followed by 
junior house officers (22.1%), and they worked in both the 
public and private sectors (62.3%). Most respondents worked 
in various shifts (53.2%) but predominantly the morning shift 
(35.1%) (See Table 1).  
 
Table 1: Baseline information of the physicians 
Physicians’ characteristics (n=77) Frequency Distribution 
Age (Year); Range: 25.0-70.0 33.0 (median) 12.5 (interquartile range) 
 Frequency Percentage 
Gender 
Male 
Female 
 
45 
32 
 
58.4 
41.6 
Job hierarchies  
Junior House Officer 
Senior House Officer 
General Practitioner 
Specialist 
Consultant 
 
17 
30 
13 
15 
2 
 
22.1 
39.0 
16.9 
19.5 
2.6 
Working sector  
Public 
Both public and private Sectors 
 
29 
48 
 
37.7 
62.3 
Working shifts  
Morning (8 am-2 pm) 
Evening (2 pm-8 pm) 
Night (8 pm-8 am) 
Multi-shift 
 
27 
7 
2 
41 
 
35.1 
9.1 
2.6 
53.2 
The bold numbers show the higher percentage.  
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The doctors surveyed slightly agreed that generic drugs should 
be prescribed according to utility (median [M] = 5.0; IQR = 2.9). 
Most of the physicians mentioned that they prescribe the drugs 
according to the patients’ needs (75.0%), evaluation of 
alternatives availability (69.0%), consumers’ perceptions of the 
drug cost (69.0%), and product brand equity (60.0%).  More 
than half of the physicians reported that they prescribe the 
drugs according to corporate brand equity (51.0%) and the 
importance of physicians’ perceptions and recognition of need 
achievement (55.0%). Close to half of them reported that they 
prescribe generic drugs according to the influence of opinions’ 
leaders (45.0%), the importance of pharma brand age (43.0%), 
and actual use of drugs by consumers (49.0%). One-third of the 
physicians reported that they prescribe the drugs according to 
the importance of consumers’ attitudes towards drugs’ 
favorability (35.0%), consumers’ intent to purchase drugs 
(30.0%), and consumers’ intentions and attitudes (31.0%), see 
Table 2.  
 
 
Table 2: Attitudes of physicians towards prescription of drugs 
Attitudes Items (n=77)    
The prescription of the drugs according to the:  Median 
(IQR) 
Agree Disagree 
Perceived utility of drugs 5.0 (2.9)   
I prescribe the drugs according to the patients’ needs. 7 (2.5) 58 (75) 10 (13) 
I prescribe the drugs to patients according to the evaluation of alternatives availability. 6 (2.0) 53 (69) 5 (6) 
I prescribe the drugs according to consumer perceptions of a price. 5 (2.0) 53 (69) 9 (12) 
I prescribe the drugs according to product brand equity. 5 (3.0) 46 (60) 20 (26) 
I prescribe the drugs according to corporate brand equity. 5 (3.0) 39 (51) 21 (27) 
I prescribe the drugs according to opinion leaders’ influence. 4 (2.0) 35 (45) 27 (35) 
I prescribe the drugs according to the importance of physicians’ perceptions and need 
achievement. 
5 (3.0) 42 (55) 22 (29) 
I prescribe the drugs according to the importance of pharma brand age in brand awareness. 4 (2.5) 33 (43) 25 (32) 
I prescribe the drugs according to the importance of customers’ attitudes towards drug’s 
favorability. 
4 (3.0) 27 (35) 34 (44) 
I prescribe the drugs according to consumers’ intend to purchase. 4 (3.0) 23 (30) 36 (47) 
I prescribe the drugs according to consumer’s intentions/attitudes. 3 (3.0) 24 (31) 41 (53) 
I prescribe the drugs according to actual use of consumers. 4 (4.0) 38 (49) 30 (39) 
    
 
The present study considered the respondents’ perception of 
drug utility when giving prescriptions to be a dependent 
variable, and other attitudes toward drug prescription—taking 
into account demographic aspects (i.e., confounders)—were 
included as independent factors in a linear regression model. 
The analysis showed that the doctors’ tendency to consider  
 
perceived drug utility differs between males and females. That 
is, the perceived utility is more important to males compared 
to females. Besides, the physicians’ perceptions of need 
achievement (P = 0.012) and the doctors’ attitudes toward 
consumers’ actual drug use (P = 0.030) predict these physicians’ 
perceptions of drug utility when filling out prescriptions (see 
Table 3). 
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Table 3: Predictors of perceived utility of prescription of drugs by physicians 
 Dependent variable: Perceived Utility    
Predictors (n=77) 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence 
Interval for B 
Beta 
Lower 
Bound 
Upper 
Bound 
Age .022 .195 .846 -.006 .007 
Gender -.234 -2.700 .009 -.227 -.034 
Education -.058 -.502 .618 -.073 .043 
Working Shifts -.020 -.216 .830 -.040 .032 
I prescribe the drugs according to the patients’ needs? .046 .388 .699 -.028 .042 
I prescribe the drugs to patients according to the evaluation 
of alternatives availability. 
.160 1.368 .177 -.015 .080 
I prescribe the drugs according to consumer perceptions of 
a price? 
.083 .734 .466 -.025 .053 
I prescribe the drugs according to product brand equity? -.132 -.858 .394 -.073 .029 
I prescribe the drugs according to corporate brand equity? .105 .713 .478 -.032 .068 
I prescribe the drugs according to opinion leaders’ 
influence? 
-.027 -.248 .805 -.041 .032 
I prescribe the drugs according to the importance of 
physicians’ perceptions and need achievement? 
.323 2.590 .012 .012 .092 
I prescribe the drugs according to the importance of 
pharma brand age in brand awareness? 
.087 .718 .476 -.025 .052 
I prescribe the drugs according to the importance of 
customers’ attitudes towards drug’s favorability. 
-.131 -.877 .384 -.064 .025 
I prescribe the drugs according to consumers’ intend to 
purchase? 
-.020 -.120 .905 -.049 .043 
I prescribe the drugs according to consumer’s 
intentions/attitudes? 
.237 1.684 .098 -.007 .076 
I prescribe the drugs according to actual use of consumers? .337 2.223 .030 .004 .080 
Linear regression was performed after a two-step of data transformation of perceived utility variable.  
As shown in Table 4, the items of perceived utility, including 
drug efficacy, branded generic drug tolerability, easy 
availability, patient satisfaction, and physicians’ on-the-job 
effectiveness were considered dependent variables, and the 
doctors’ attitudes and confounders were included as 
independent variables in multivariate testing. The analysis 
revealed that males significantly more often consider branded 
generic drug tolerability (P = 0.049) and their own on-the-job 
effectiveness (P = 0.034). Similarly, junior house officers (P = 
0.018), older doctors (P = 0.026), and physicians who take into 
account their perceptions of need achievement (P = 0.004) 
significantly more often consider their on-the-job effectiveness 
when prescribing drugs. In addition, the doctors who more 
strongly consider need achievement (P < 0.001) and drug cost 
(P = 0.006) more often take into account branded generic drug 
tolerability. Finally, the doctors’ perceptions of consumers’ 
actual drug use predicted these physicians’ perceptions of 
drugs’ easy availability (P < 0.001) (see Table 4).  
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Table 4: Predictors of items of perceived utility in the prescription of drugs 
Predictors (n=77) Dependent Variables 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
Gender Tolerability of the generic drugs 6.087 4.051 .049 .069 
Effectiveness of physician job 10.328 4.750 .034 .079 
Job Hierarchies The effectiveness of physician job 7.065 3.249 .018 .191 
Age Effectiveness of physician job 11.450 5.266 .026 .087 
Perceived Cost Tolerability of the generic drugs 12.207 8.124 .006 .129 
Need Achievement Tolerability of the generic drugs 22.351 14.874 <.001 .213 
Effectiveness of physician job 19.382 8.914 .004 .139 
Actual Use Easy availability 34.667 16.047 <.001 .226 
 
Multivariate tests were performed for statistical analysis. The non-significant predictors were not shown in this table.  
 
Discussion 
The present study sought to examine the predictors of 
physicians’ perceptions of drug utility when issuing 
prescriptions. The doctors surveyed agreed that drugs must be 
prescribed according to their utility, and the respondents also 
strongly agreed that prescribed drugs should be in accordance 
with patients’ needs. The physicians’ perceptions of need 
achievement and consumers’ actual drug use were associated 
with doctors’ perceptions of drug utility while filling out 
prescriptions.  
The respondents’ most negative attitudes were that they only 
slightly agreed that drugs should be prescribed according to 
their utility. However, the positive attitude is that they reported 
that they strongly agreed that they should prescribe generic 
drugs in accordance with patients’ needs. These negative 
attitudes have also been detected in physicians’ perceptions in 
other countries. Theodorou et al 24 reported that many doctors 
do not consider generic drugs’ effectiveness, safety, and 
efficacy to be the most important factors when prescribing 
drugs. The current investigation found that the factor 
contributing the most to the respondents’ perceived drug utility 
is easy availability, which is strongly predicted by the doctors’ 
perceptions of consumers’ actual drug use (effect size = 0.226). 
In addition, generic drugs tolerability is strongly predicted by 
physicians’ perceived need achievement (effect size = 0.213).  
An eight-step approach to appropriate prescribing medications 
recommends that the patients’ issues must be evaluated and 
clearly defined before prescribing drugs.29 The physicians are 
respected to recognize the right of need of their patients and 
suggest drugs for the well-being of their patients. The relation 
of the physicians with pharmaceutical companies may create a 
conflict between the ethical professional interest and its 
financial self-interest.30 The close link between the 
pharmaceutical industry and prescribing drug by doctor has 
been reported in Iraqi Kurdistan as well.12 The scholars reported 
that there is a positive association between patients and 
requests and prescribing drugs.31, 32 It seems that this kind of 
association is driven by the pressure of patient. Kravitz et al 31 
reported that when physicians do not comply with patient 
requests, their patients are less satisfied with the physician 
practice.  
We postulated that junior and older doctors and those 
physicians who value need achievement to consider their on-
the-job effectiveness is important to keeping clients satisfied in 
both the public and private sectors. Junior doctors with less 
experience were expected to have fewer clients compared to 
those with higher levels of education and experience. Sanyal et 
al 26 also found that product brand equity, corporate brand 
equity, perceived cost, and opinion leaders’ influence have a 
substantial impact on drugs’ perceived utility. These factors 
determine the relationship between perceived drug utility and 
physicians’ perceptions, attitudes, and need achievement.  
Drugs’ cost does not predict doctors’ attitudes toward 
prescribing drugs according to their perceived utility, even 
though the respondents slightly agreed that price needs to be 
considered in drug prescription. Theodorou et al 24 highlighted 
that cost is important to 46.6% and 51.3% of Greek and Cypriot 
physicians, respectively, while the cost is highly important to 
16.0% and 11.4% of both groups of doctors, respectively. Drug 
cost in the present study only predicted generic drugs 
tolerability . Cost may thus be more important to patented 
drugs than to genetic drugs because the former is more 
expensive. Moreover, generic drugs’ tolerability and physicians’ 
on-the-job effectiveness are predicted by doctors’ need 
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achievement. Generic drugs also may not be suitable for 
patients under certain conditions.33  
One of the main factors which was associated with the 
perceived utility of drugs by physicians was the physicians’ 
perceptions of the actual use of drugs by consumers in this 
region. The official reports from Iraq mentioned that a higher 
proportion of Iraqi cardiac patients (64.3%) reported a 
medium/low level of adherence to their medications. The 
patients’ beliefs about cardio-protective medications were 
determined to be an independent predictor of cardiac 
medication adherence.34 We hypothesize that the physicians 
may have an experience of a high non-adherence to medication 
among their patients, which is perceived utility is slightly 
important to them. Particularly, non-adherence to medicines is 
common in patients with chronic disease and those who 
prescribed preventive medications in other countries as well.35  
Physicians play an important role in determining whether 
patients need branded or generic drugs. This decision has an 
impact on doctors’ effectiveness when prescribing drugs, which 
varies by gender, age, and position in job hierarchies in the 
region under study. The perceived cost has previously been 
found to hinder consumers’ actual drug use. However, the 
present study found that drugs’ cost does not affect physicians’ 
need achievement and their perception of consumers’ actual 
drug use. Therefore, cost most probably does not influence 
perceived quality as generic drugs are cheaper than branded 
drugs. The former is frequently prescribed by physicians in 
Middle Eastern countries.11, 25 Also, the cost could be important 
for doctors who have patients with chronic diseases. Generic 
drugs are also compatible in terms of quality with branded 
drugs. Since no system for pharmaceutical reimbursement 
exists in the local health system of the region covered by the 
present study, doctors may encounter difficulties when 
prescribing either expensive or cheap versions of drugs in some 
circumstances.  
Overall, this study did not find that the availability of alternative 
drugs predicts drugs’ perceived utility, in contrast with the 
literature.36 A large number of pharmaceutical companies sell 
products in Iraqi Kurdistan. Therefore, patients probably do not 
have any difficulty finding alternative drugs. The main obstacle 
in the way of improvement of prescribing drug practices is that 
general practitioners, or family doctors do not fill the role of 
gatekeepers in the region’s healthcare system. More 
specifically, the private sector’s size and influence are 
increasing in terms of freelancers, diagnostic settings, and 
hospitals.  
 
Implications for research  
Researchers need to examine further Iraqi Kurdistan physicians’ 
perceptions of generic drugs’ utility in terms of consumers’ 
actual drug use because irrational and inappropriate drug 
prescriptions have adverse effects on clients. In addition, we 
expect that the health authorities have not adequate 
supervision on physicians’ drug prescription behaviors in this 
region. 
 
Strengths and limitations 
This study is one of the few investigations which was designed 
to examine the factors contributing to doctors’ perceptions of 
drug utility, according to the existing literature. Another 
strength is that a structured questionnaire was developed 
specifically to serve the research’s purposes. Furthermore, 
most previous studies have focused on analyses of a single 
factor, thus failing to consider many confounding factors 
affecting physicians’ prescription behaviors.  
However, this study had limitations as well. The data were 
collected with a self-report technique, which can introduce 
bias. In addition, the small sample was taken from one 
geographic area, making difficulties to generalize the findings 
to other settings in the rest of Iraq. The influence of 
pharmaceutical sales practices on doctors’ decision making was 
not included in this research because pharmaceutical sales 
representatives are not allowed to visit the public sector in the 
region under study. Moreover, they play a large role in 
physicians’ decisions about new drug prescriptions, which were 
not considered here.37, 38 Besides, the low response rate of 
physicians may have an effect on findings reported in this study.  
 
Conclusions 
The present study’s results suggest that doctors agree slightly 
that drugs should be prescribed according to their utility and 
concur strongly that patients’ needs must be considered. The 
findings include that physicians’ perceptions of need 
achievement and patients’ actual drug use predict drugs’ 
perceived utility.  
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